# Millennium Management LLC

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/millennium-management-llc-company
Canonical HTML page: https://getyourbrief.com/entity/millennium-management-llc-company

## Recent coverage (3 stories, network-wide)

### Collegium Pharma EPS Beats by $0.20; Revenue Grows 6.3% to $199.88M
2026-08-09 18:29:04 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Collegium Pharmaceutical's Q2 2026 earnings beat signals sustained demand for its abuse-deterrent pain medications. Revenue grew 6.3% to $199.88M, and EPS of $1.92 surpassed forecasts by $0.20, indicating commercial strength despite regulatory pressures.
Full story: https://gethealthbrief.com/story/collegium-pharma-q2-2026-earnings-health

### COLL Beats Q2 EPS by $0.20, Stock Gains 1.24% to $29.47
2026-08-09 18:28:55 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Collegium Pharmaceutical delivered an 11.6% EPS beat and modest revenue beat, lifting shares to $29.47. High ROE and institutional accumulation offset by high leverage and mixed analyst ratings create a nuanced investment case.
Full story: https://getfinancebrief.com/story/collegium-pharma-q2-2026-earnings-finance

### COLL Q2 EPS Beats by $0.20; Revenue Up 6.3% to $199.88M
2026-08-09 18:28:47 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Collegium Pharmaceutical's earnings beat of $0.20 per share, reaching $1.92 on $199.88M revenue, highlights its commercial success in the abuse-deterrent opioid space, a key sector for the biopharma industry.
Full story: https://getbiobrief.com/story/collegium-pharma-q2-2026-earnings-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.